Renovaro Inc. (RENB)

Profile

Full Name

Renovaro Inc.

Ticker

NASDAQ: RENB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 7, 2018

Indexes

Not included

Website

https://renovarogroup.com

Employees

25

Key Details

Price

$0.18(-4.19%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$0.84(-18.31% YoY)

PE ratio

-

Next earnings date

Sep 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.18
    RENB price is $0.18

    30-Day Relative Volume

    2.88
    RENB 30-day relative volume is 2.88

    Price Performance

    Price Most recent change

    -4.19%
    RENB price was down -4.19% on Sep 16, 2025

    Price YTD change

    -78.11%
    RENB price is down -78.11% since January 1st

    Price 1-year change

    -71.32%
    RENB price is down -71.32% year-on-year

    Price 3-year change

    -91.68%
    RENB price is down -91.68% over the past 3 years

    Price Range

    Price All-time high

    $13.78
    RENB price is currently -98.67% below its historical high of $13.78

    Price 3-year low

    $0.17
    RENB price is currently +7.65% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $31.50M
    RENB market capitalization is $31.50 million

    Market cap 3-year change

    -72.99%
    RENB market capitalization is down -72.99% over the past 3 years

    Market cap All-time high

    $655.36M
    RENB market capitalization is currently -95.19% below its historical high of $655.36 million

    Market cap sector rank

    27.1%
    RENB market capitalization is higher than 27.1% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +11.02%
    RENB shares outstanding is up +11.02% year-on-year

    Shares Outstanding 3-Year Change

    +224.71%
    RENB shares outstanding is up +224.71% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.23
    RENB beta is 1.23

    200-day SMA

    $0.57
    RENB price is currently -68.01% below its 200-day simple moving average

    50-day SMA

    $0.26
    RENB price is currently -28.24% below its 50-day simple moving average

    RSI

    35.24
    RENB 14-day relative strength index is 35.24

    Volume

    2.88
    RENB 30-day relative volume is 2.88

    ATR

    $0.02
    RENB average true range is $0.02

    10-day Historical Volatility

    117.77%
    RENB 10-day historical volatility is 117.77%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    RENB annual revenue is $0.00

    Revenue Analysts estimate

    -
    RENB annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    RENB annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    RENB annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$0.84
    RENB annual earnings per share is -$0.84

    EPS Analysts estimate

    -
    RENB annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -18.31%
    RENB annual earnings per share is down -18.31% year-on-year

    EPS Sector rank

    55.42%
    RENB annual earnings per share is higher than 55.42% of companies in Healthcare sector

    Profit

    Gross profit

    -$121.90K
    RENB annual gross profit is -$121.90 thousand

    Gross margin

    -
    RENB annual gross profit margin value is unknown

    Operating profit

    -$27.39M
    RENB annual operating income is -$27.39 million

    Operating margin

    -
    RENB annual operating profit margin value is unknown

    Net income

    -$80.65M
    RENB annual net profit is -$80.65 million

    Net margin

    -
    RENB annual net profit margin value is unknown

    Expenses

    Total expenses

    $80.65M
    RENB annual total expenses is $80.65 million

    Operating expenses

    $27.27M
    RENB annual total operating expenses is $27.27 million

    Cost of goods sold

    $121.90K
    RENB annual cost of goods sold is $121.90 thousand

    Selling, general & administrative expenses

    $24.56M
    RENB annual SGA is $24.56 million

    Depreciation and amortization

    $121.90K
    RENB annual depreciation & amortization is $121.90 thousand

    Interest expense

    $0.00
    RENB annual interest expense is $0.00

    Income tax

    $0.00
    RENB annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$27.39M
    RENB annual earnings before interest & taxes is -$27.39 million

    EBITDA

    -$27.27M
    RENB annual EBITDA is -$27.27 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $163.13M
    RENB annual total assets is $163.13 million

    Non current assets

    $161.13M
    RENB annual long term assets is $161.13 million

    Current assets

    $2.00M
    RENB annual total current assets is $2.00 million

    Cash and cash equivalents

    $220.50K
    RENB annual cash & cash equivalents is $220.50 thousand

    Accounts receivable

    -
    RENB annual accounts receivable value is unknown

    Inventory

    $0.00
    RENB annual inventory is $0.00

    Liabilities

    Total liabilities

    $31.15M
    RENB annual total liabilities is $31.15 million

    Long term liabilities

    $842.40K
    RENB annual total long term liabilities is $842.40 thousand

    Current liabilities

    $30.31M
    RENB annual total current liabilities is $30.31 million

    Accounts payable

    $9.45M
    RENB annual accounts payable is $9.45 million

    Debt

    Total debt

    $3.79M
    RENB annual total debt is $3.79 million

    Total debt 1-year change

    -32.3%
    RENB annual total debt is down -32.3% year-on-year

    Long term debt

    $842.40K
    RENB annual long term debt is $842.40 thousand

    Short term debt

    $2.94M
    RENB annual short term debt is $2.94 million

    Equity & Capital

    Shareholders equity

    $131.98M
    RENB annual stockholders equity is $131.98 million

    Book value

    $134.89M
    RENB annual book value is $134.89 million

    Retained earnings

    -$324.68M
    RENB annual retained earnings is -$324.68 million

    Working capital

    -$28.31M
    RENB annual working capital is -$28.31 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$10.97M
    RENB annual cash flow from operations is -$10.97 million

    Cash from operations 1-year change

    +6.82%
    RENB annual cash flow from operations is up +6.82% year-on-year

    Cash from investing

    -$1.26M
    RENB annual cash flow from investing activities is -$1.26 million

    Cash from investing 1-year change

    -4128.86%
    RENB annual cash flow from investing activities is down -4128.86% year-on-year

    Cash from financing

    $10.52M
    RENB annual cash flow from financing activities is $10.52 million

    Cash from financing 1-year change

    +132.94%
    RENB annual cash flow from financing activities is up +132.94% year-on-year

    CAPEX

    CAPEX

    $70.40K
    RENB annual capital expenditures is $70.40 thousand

    CAPEX 1-year change

    +136.24%
    RENB annual capital expenditures is up +136.24% year-on-year

    Free Cash Flow

    Free cash flow

    -$11.04M
    RENB annual free cash flow is -$11.04 million

    Free cash flow 1-year change

    +6.46%
    RENB annual free cash flow is up +6.46% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    RENB annual gross profit margin value is unknown

    Operating margin

    -
    RENB annual operating profit margin value is unknown

    Net margin

    -
    RENB annual net profit margin value is unknown

    ROA & ROE

    ROA

    -72.84%
    RENB annual return on assets is -72.84%

    ROE

    -90.37%
    RENB annual return on equity is -90.37%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    RENB price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    RENB price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.36
    RENB price to book ratio is 0.36

    PB ratio Sector rank

    21.63%
    RENB price to book ratio is higher than 21.63% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    RENB price to sales ratio value is unknown

    PS ratio Sector rank

    -
    RENB price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $36.90M
    RENB enterprise value is $36.90 million

    Enterprise value Sector rank

    35.11%
    RENB enterprise value is higher than 35.11% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.57
    RENB EV/EBITDA is -0.57

    EV/EBITDA Sector rank

    52.83%
    RENB EV/EBITDA is higher than 52.83% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.07
    RENB annual current ratio is 0.07

    Quick ratio

    0.07
    RENB annual quick ratio is 0.07

    Leverage

    Debt to equity

    0.03
    RENB annual debt to equity ratio is 0.03

    Interest coverage ratio

    -
    RENB annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    RENB piotroski f-score value is unknown

    Altman Z-Score

    -2.94
    RENB altman z-score is -2.94

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with RENB included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Renovaro Inc.?
    • Does Renovaro Inc. pay dividends?
    • What sector is Renovaro Inc. in?
    • What industry is Renovaro Inc. in?
    • What country is Renovaro Inc. based in?
    • When did Renovaro Inc. go public?
    • Is Renovaro Inc. in the S&P 500?
    • Is Renovaro Inc. in the NASDAQ 100?
    • Is Renovaro Inc. in the Dow Jones?
    • When was Renovaro Inc.'s last earnings report?
    • When does Renovaro Inc. report earnings?

    What is the ticker symbol for Renovaro Inc.?

    The ticker symbol for Renovaro Inc. is NASDAQ:RENB

    Does Renovaro Inc. pay dividends?

    No, Renovaro Inc. does not pay dividends

    What sector is Renovaro Inc. in?

    Renovaro Inc. is in the Healthcare sector

    What industry is Renovaro Inc. in?

    Renovaro Inc. is in the Biotechnology industry

    What country is Renovaro Inc. based in?

    Renovaro Inc. is headquartered in United States

    When did Renovaro Inc. go public?

    Renovaro Inc.'s initial public offering (IPO) was on February 7, 2018

    Is Renovaro Inc. in the S&P 500?

    No, Renovaro Inc. is not included in the S&P 500 index

    Is Renovaro Inc. in the NASDAQ 100?

    No, Renovaro Inc. is not included in the NASDAQ 100 index

    Is Renovaro Inc. in the Dow Jones?

    No, Renovaro Inc. is not included in the Dow Jones index

    When was Renovaro Inc.'s last earnings report?

    Renovaro Inc.'s most recent earnings report was on April 23, 2025

    When does Renovaro Inc. report earnings?

    The next expected earnings date for Renovaro Inc. is September 29, 2025
    On this page